Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Urologix CEO Stryker Warren To Retire

Urologix, Inc. (ULGX: Quote) said Tuesday that Stryker Warren jr. has decided to retire as CEO and a member of the company's Board of Directors, effective November 30.

The company said its Chief Operating Officer Greg Fluet will become interim CEO following Warren's retirement.

Fluet joined the company as its Executive Vice President and Chief Operating Officer in July 2008. Prior to joining Urologix, he was an Associate at Sapient Capital Management, LLC, a venture capital firm focused on medical devices.

Warren came out of retirement to join Urologix as CEO in June 2008. He had previously been the President and CEO of Urology Healthcare Group whose wholly owned subsidiary, Urotech, remains Urologix' largest customer.

Click here to receive FREE breaking news email alerts for UROLOGIX INC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The... Stocks showed a lack of direction over the course of the trading day on Friday after failing to sustain an initial upward move. Despite the choppy trading, the Dow once again managed to end the session at a new record closing high. The major averages turned in a mixed performance on the day. President Barack Obama delivered a statement Thursday evening thanking members of Congress for voting to approve legislation granting the U.S. military the authority to train and arm moderate Syrian rebels fighting against the terrorist group known as the Islamic State.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.